Medication info
Nobasartan Tablets 5/80mg

Nobasartan Tablets 5/80mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Il Yang Biopharm Co., Ltd.
Appearance
Dark yellow circular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201508519 · Approved 2015.12.30 · Insurance code 696601170

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted; however, a direct switch to this medication may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher), but this medication should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Use of this medication is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Il Yang Biopharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medicine is used when blood pressure is not sufficiently controlled with monotherapy using amlodipine or valsartan. It helps to effectively lower blood pressure in patients with essential hypertension. This drug contributes to stable management of blood pressure by dilating blood vessels, thereby reducing the risk of cardiovascular diseases related to hypertension.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted; however, a direct switch to this medication may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher), but this medication should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Older adults aged 65 years or older: Use caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Use of this medication is not recommended because its safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus and neonates when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with a known allergy to this medication, pregnant or breastfeeding women, patients with severe renal or liver dysfunction, and patients with a history of certain heart diseases or angioedema should not take this drug. In patients with sodium or fluid depletion, hypotension may occur, so their condition should be carefully checked before administration, and if symptoms of hypotension occur during use, they should be laid down immediately and receive intravenous fluids if necessary. Patients with high potassium levels or those taking potassium supplements should have their potassium levels monitored frequently, and caution is also required for patients with impaired renal function. This drug should be used with caution in patients with heart failure, myocardial infarction, or severe liver dysfunction, and blood pressure and kidney function should be regularly monitored during treatment. Care should be taken when driving or operating machinery as dizziness or fatigue may occur. There may be interactions when this drug is used in combination with other antihypertensives, diuretics, potassium-sparing drugs, certain anti-inflammatories (NSAIDs), and specific antibiotics, so consultation with a physician is recommended. Pregnant women or those planning to become pregnant should not take this drug, and breastfeeding women are also advised to avoid it. Safety and efficacy in pediatric patients under 18 years of age have not been sufficiently established, so its use is not recommended. Overdosage may lead to hypotension, dizziness, arrhythmia, etc., and immediate medical assistance should be sought. It is important to consult a physician or pharmacist immediately if any adverse effects or unusual symptoms occur while taking this medication.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, serum sickness including hypersensitivity, serum potassium increase, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, serum creatinine increase, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory impairment, taste disorder, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug's efficacy and safety for an extended period.

Appearance and packaging

Appearance

Dark yellow circular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.